APPLICATION SITE JOINT ERYTHEMA

This adverse event was reported 9 times

APPLICATION SITE JOINT ERYTHEMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EFINACONAZOLE 1 0.0005
1 CAPSAICIN 1 0.0003
2 PIPERACILLIN AND TAZOBACTAM 1 0.0001
3 PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM 1 0.0001
4 DICLOFENAC SODIUM 6 0.0000
5 PIPERACILLIN SODIUM,TAZOBACTAM SODIUM 1 0.0000
6 DICLOFENAC SODIUM 1% 1 0.0000
7 DICLOFENAC SODIUM TOPICAL GEL, 1% 1 0.0000
8 ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE 2 0.0000
9 ACETAMINOPHEN 2 0.0000
See all drugs enriched for association with APPLICATION SITE JOINT ERYTHEMA

These drug classes are most commonly taken by patients reporting APPLICATION SITE JOINT ERYTHEMA:

# Drug class Count
0 Expectorant [EPC] 2
1 Azole Antifungal [EPC] 1
See all common drug classes associated with APPLICATION SITE JOINT ERYTHEMA

APPLICATION SITE JOINT ERYTHEMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Expectorant [EPC] 2 0.0000
1 Azole Antifungal [EPC] 1 0.0000
See all drug classes enriched for association with APPLICATION SITE JOINT ERYTHEMA